… molnupiravir vs. placebo [Citation14]. In addition, molnupiravir has shown promising efficacy
and safety … Studies have shown that molnupiravir reduces the risk of hospitalization or death …

… The aim of this study was to evaluate the safety profile of molnupiravir in … meta-analysis
on the AEs of various doses of molnupiravir versus placebo using Comprehensive Meta-Analysis …

… There are currently some differences in the research results of molnupiravir. This study
aimed to evaluate the efficacy and safety of molnupiravir in the treatment of COVID-19. …

… Molnupiravir was safe during the study period in outpatients … Our analysis does not support
routine use of molnupiravir for … evaluating the efficacy and safety of molnupiravir in order to …

… Overall, the findings of the present work are consistent with those of another meta-analysis
of 6 RCTs involving 3481 patients. In the present study, molnupiravir was effective in reducing …

… and safety of nirmatrelvir/ritonavir (Paxlovid) with molnupiravir in the … Data were analyzed
using Comprehensive Meta-Analysis … 57 659 patients were included in the meta-analysis. The …

… Several trials of molnupiravir have been in … meta-analysis to increase the statistical power
of the available evidence by combining it and evaluating the safety and efficacy of molnupiravir …

… This systematic review represents the most comprehensive summary thus far of the efficacy
and safety of molnupiravir in treating patients with mild-to-moderate COVID-19. Our findings …

… the efficacy and safety of molnupiravir need reassessment… safety of molnupiravir for the
treatment of non-severe (mild or moderate) COVID-19, and conduct subgroup analyses and meta-…

… However, it should be noted that this meta-analysis included eight studies that assessed …
, molnupiravir and fluvoxamine, and many of the included studies from that meta-analysis were …